Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.

HB 127 protects pharmacists from disciplinary action by the State Board of Pharmacy or employers for recommending or dispensing drugs for off-label uses (using a drug in a way not approved by the FDA, based on a healthcare provider’s prescription). It also prohibits pharmacy benefits managers from retaliating against pharmacists or their employers for such actions and allows pharmacists to sue if terminated for this reason. The bill additionally permits over-the-counter sales of Ivermectin (for human use) and Hydroxychloroquine without a prescription. These changes apply to pharmacists and pharmacies in Alabama, excluding controlled substances. The bill is pending in the House Health Committee as of January 2026.